Evidence map›Paper›PMID 18172031›Full record

ArticleCirculation2008

Noninvasive in vivo imaging of monocyte trafficking to atherosclerotic lesions.

Moritz F Kircher, Jan Grimm, Filip K Swirski, Peter Libby, Robert E Gerszten, Jennifer R Allport, Ralph Weissleder

Abstract read
In one paragraph

Article in Circulation, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. Review
  2. Review
  3. Anti-atherosclerotic therapies: Milestones, challenges, and emerging innovations.Molecular therapy : the journal of the American Society of Gene Therapy · 2022
    Review
  4. Review
  5. Direct Cell Radiolabeling forChemical reviews · 2022
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Quantifying progression and regression of thrombotic risk in experimental atherosclerosis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2015
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Moritz F KircherCenter for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, Charlestown, Mass, USA.
Jan Grimm
Filip K Swirski
Peter Libby
Robert E Gerszten
Jennifer R Allport
Ralph Weissleder

Funding

Translational Program of Excellence in NanotechnologyU01HL080731 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2005 to 2009
$14.9M
Small Animal Imaging Resource GrantR24CA092782 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, RALPH · 2001 to 2006
$4.2M
NCI NIH HHS R24 CA092782NCI NIH HHS R24 CA92782NHLBI NIH HHS U01 HL080731
6 · The paper itself

Abstract

backgroundMonocytes play a key role in atherogenesis, but their participation has been discerned largely via ex vivo analyses of atherosclerotic lesions. We sought to establish a noninvasive technique to determine monocyte trafficking to atherosclerotic lesions in live animals. METHODS AND

resultsUsing a micro-single-photon emission computed tomography small-animal imaging system and a Food and Drug Administration-approved radiotracer ([indium 111] oxyquinoline, (111)In-oxine), we demonstrate here that monocyte recruitment to atherosclerotic lesions can be visualized in a noninvasive, dynamic, and 3-dimensional fashion in live animals. We show in vivo that monocytes are recruited avidly to plaques within days of adoptive transfer. Using micro-single-photon emission computed tomography imaging as a screening tool, we were able to investigate modulatory effects on monocyte recruitment in live animals. We found that 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors rapidly and substantially reduce monocyte recruitment to existing atherosclerotic lesions, as imaged here in vivo.

conclusionsThis novel approach to track monocytes to atherosclerotic plaques in vivo should have broad applications and create new insights into the pathogenesis of atherosclerosis and other inflammatory diseases.

Indexed as

Chemotaxis, LeukocyteAdoptive TransferAnimalsApolipoproteins EAtherosclerosisGreen Fluorescent ProteinsMiceMice, KnockoutMice, TransgenicMonocytesOrganometallic CompoundsOxyquinolineTomography, Emission-Computed, Single-PhotonApolipoproteins EGreen Fluorescent Proteinsindium oxineOrganometallic CompoundsOxyquinoline

Identifiers

PMID18172031
PMCPMC2705289

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.